SANA · Sana Biotechnology, Inc.
$3.80
-0.12 (-3.06%)
At close · Sep 4
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.17B
Shares
299.36M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-07 | 11,069 | $3.41 | $37,745 |
| 2026-07-27 | 75,545 | $3.18 | $240,233 |
| 2026-07-17 | 47 | $3.17 | $149 |
| 2026-07-10 | 116 | $3.93 | $456 |
| 2026-06-29 | 636,457 | $3.42 | $2,176,683 |
| 2026-06-16 | 84 | $2.85 | $239 |
| 2026-06-12 | 48 | $2.77 | $133 |
Showing 1–7 of 7 settlements
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
165 filings
164 filers
Visit website
Investor relations